Drugs / quazepam
quazepam
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | DORAL | — | 1985-12-27 | fda.gov ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00707915 | Jan 2008 → Jul 2010 | — | Minamihanno Hospital | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | quazepam | “BZD-derivative hypnotics will include brotizolam, flunitrazepam, etizolam, quazepam, estazolam, nitrazepam, flurazepam, and diazepam.” NCT00707915 ↗ |
| Known as | Doral | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200472 ↗ |
| Known as | NSC-309702 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200472 ↗ |
| Known as | Quazepam civ | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200472 ↗ |
| Known as | SCH 16134 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200472 ↗ |
| Modality | Small molecule | — CHEMBL1200472 ↗ |